Relative to its peers, OGEN does not have very much institutional sponsorship. The 9.57% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JANNEY MONTGOMERY SCOTT LLC Bought 14.9 Thousand shares of Oragenics Inc
MERRILL LYNCH, PIERCE, FENNER & ... Sold 91.00 shares of Oragenics Inc
TOWER RESEARCH CAPITAL LLC Sold 500.00 shares of Oragenics Inc